Schizophrenia is a complex neurodevelopmental disorder with impaired cognitive function as a major element. BDNF may be a marker of abnormal neuronal development and neurotransmission in schizophrenia. Cognitive function ...

Schizophrenia is a dramatic mental illness with tragic manifestation. The consequences of the illness are for the individual, affected his or her family and society. Schizophrenia is one of the twenty illness that causes ...

Schizophrenia is a complex neurodevelopmental disorder with cognitive impairment as the main part. BDNF regulates aspects of developmental plasticity in the brain and is involved in cognitive function. Cognitive functions ...

Schizophrenia is a heterogeneous disorder in which there is an interaction between genetic and environmental factors. Evidence related to vitamin D deficiency and schizophrenia is aresidence.Because influenced by ...

The most common of psychotic disorders is schizophrenia. While evaluating the cognitive function with a standardized test, the intelligence test is by using the IQ test. For schizophrenic patients, intelligence is usually ...

Folic acid deficiency is a risk factor for schizophrenia through epidemiology, biochemistry and gene-related studies. Compared with healthy people, schizophrenic patients may have high homocysteine plasma values and ...

Background: Schizophrenia is characterized as a psychiatric disorder with symptoms of complex dimension. Poor prognosis contained in several cognitive functions resulting in difficulties in social, academic, and adaptation ...

Dementia is a disease that is most common and most damaging in the elderly. Nearly 4.6 million new cases are found each year and is found in the number doubled every 20 year and it is estimated there are 81.1 million people ...

Background- Vitamin D levels with schizophrenia is lower than the control due to lifestyle and physical health factors such as smoking, inactivity, and social withdrawal including decreases of sunlight exposure. Asia has ...

Mental disorders constitute 13% of the global disease burden. Schizophrenia, major depressive disorders (MDD) and bipolar disorders are among the most disabling disorders. Some of the inflammatory markers such as ...